The first stop for professional medicines advice

Administering, Supply

18 results

RelevanceNewest firstOldest firstTitle
Applied filters

Off-label or unlicensed products and Schedule 17 of the Human Medicines Regulations 2012 exemptions

8 January 2020The below summary details the legal position regarding the sale, supply or administration of off-label/ unlicenced products under Schedule 17 of the HMR 2012

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Direction (PGDs) for in End of Life Care

Acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings

Transcribing in the patient's home with healthcare input

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Worked example of assessing the risk of transcribing

22 February 2022Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.

Supply and/or administration of abortifacients under Patient Group Directions

14 September 2020This Q&A advises on the legal position on the supply/administration of abortifacients under PGDs.

Mixing of medicines and Patient Group Directions

9 September 2020This Q&A provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Using a Patient Group Direction to adjust doses of medicines

16 November 2021This article outlines why PGDs cannot be used to adjust the dosage of a medicine already in an individual's possession

Off-label medicine use under a Patient Group Direction

10 June 2021The below summary explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label')